glp-3rt vs retatrutide What GLP‑3 Really Is: Triple‑Receptor Drug GLP-3 RETA - NuRev Peptides

June 26th, 2024: Study reveals GLP-1 drugs may cause bone density loss without exercise A recent study from the University of Copenhagen raises new concerns about GLP-1 medications, including Ozempic, Wegovy, and Mounjaro, highlighting potential bone density loss

Take your Wegovy pill on an empty stomach in the morning with water (up to 4 ounces)

GLP-1 medications reduce appetite so effectively that many patients simply do not eat enough to meet their micronutrient needs

Blood glucose monitoring may be advisable for patients taking GLP-1 medications alongside insulin or sulfonylureas, as these combinations increase hypoglycaemia risk

Many of my patients naturally gravitate toward lighter, more nutritious foods because heavy meals become less appealing

Your dose of thyroid medication is often influenced by body weight, and substantial weight loss can make a previously appropriate dose too strong